TABLE 2.

Demographics, mean performance, and survey results of “scorable” participants

		Age	Sex	Education				Test preference (%)
Participant source	n	(years)	(%women)	(years)	MoCA	SATURN	%Report SATURN “Easy to Use”	MoCA	No Pref.	SATURN
Study partner	37	65.5 ± 9.2	59	16.3 ± 2.5	27.0 ± 1.8	27.1 ± 2.6	97	8	30	62
Dementia clinic	24	71.5 ± 10.3	46	15.5 ± 3.0	19.1 ± 6.1	17.5 ± 6.4	63	42	38	21
Not Demented a	4	74.3 ± 6.1	50	15.8 ± 1.6	24.8 ± 3.8	24.3 ± 4.1	75	25	75	0
Alzheimer's b	13	68.5 ± 11.3	46	16.4 ± 2.6	18.5 ± 5.6	16.4 ± 6.0	54	54	31	15
Other Dementia c	7	75.6 ± 9.2	29	13.7 ± 3.8	16.9 ± 6.6	15.7 ± 6.2	71	29	29	43
Other Clinic	14	65.9 ± 7.6	36	15.5 ± 3.6	24.8 ± 3.3	23.6 ± 3.6	79	21	29	50
Multiple Sclerosis	2	62.5 ± 7.8	100	15.0 ± 1.4	28.0 ± 1.4	26.5 ± 2.1	100	50	‐	50
Essential Tremor	1	66	100	14	27	25	100	‐	‐	100
Parkinson	11	66.5 ± 8.2	18	15.7 ± 4.0	24.0 ± 3.3	23.0 ± 3.7	73	18	36	45

Shaded rows break down patients from each clinic into more specific diagnoses. Other than group sizes (n), data are presented as percentages or as mean ± standard deviation. The MoCA and SATURN are scored out of 30 points.

^aIncludes three patients with mild cognitive impairment, and a cognitively normal carrier of an apolipoprotein E (APOE) ε4 allele

^bThe clinical diagnosis was Alzheimer's disease for all but one, for whom cerebrospinal fluid implicated Alzheimer's disease as the cause of corticobasal syndrome

^cIncludes one case of Lewy body dementia, three cases predominantly or exclusively caused by cerebrovascular disease, and another three of mixed or uncertain cause. To simplify presentation, this row includes a patient with known dementia who was seen in general neurology clinic for peripheral neuropathy on the day of testing (and therefore not assigned CDR scores).